WallStreetZenWallStreetZen

NASDAQ: BTAI
Bioxcel Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BTAI past revenue growth

How has BTAI's revenue growth performed historically?
Company
268%
Industry
148.4%
Market
16.96%
BTAI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BTAI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BTAI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BTAI earnings and revenue history

Current Revenue
$1.4M
Current Earnings
-$179.1M
Current Profit Margin
-12,974.9%

BTAI Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when BTAI announces earnings.

BTAI Return on Assets

Current Company
-144.9%
Current Industry
2.9%
BTAI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BTAI Return on Capital Employed

Current Company
-356.93%
Current Industry
19.5%
BTAI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BTAI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BTAI$1.38M-$165.42M-$179.05M+268.00%N/A
ALRN$0.00-$15.61M-$15.73MN/AN/A
HOOK$20.13M-$77.34M-$81.58M+21.41%N/A
LPTX$0.00-$81.40M-$81.41M-100.00%N/A
RVPH$0.00-$39.24M-$39.26MN/AN/A
View Top Biotech Stocks

BTAI earnings dates

Next earnings date
May 6, 2024

Bioxcel Therapeutics Earnings & Revenue FAQ

What were BTAI's earnings last quarter?

On Invalid Date, Bioxcel Therapeutics (NASDAQ: BTAI) reported Q4 2023 earnings per share (EPS) of -$0.75, up 61.73% year over year. Total Bioxcel Therapeutics earnings for the quarter were -$22.26 million. In the same quarter last year, Bioxcel Therapeutics's earnings per share (EPS) was -$1.96.

If you're new to stock investing, here's how to buy Bioxcel Therapeutics stock.

What was BTAI's earnings growth in the past year?

As of Q2 2024, Bioxcel Therapeutics's earnings has grown year over year. Bioxcel Therapeutics's earnings in the past year totalled -$179.05 million.

What is BTAI's earnings date?

Bioxcel Therapeutics's earnings date is Invalid Date. Add BTAI to your watchlist to be reminded of BTAI's next earnings announcement.

What was BTAI's revenue last quarter?

On Invalid Date, Bioxcel Therapeutics (NASDAQ: BTAI) reported Q4 2023 revenue of $376.00 thousand up 57.98% year over year. In the same quarter last year, Bioxcel Therapeutics's revenue was $238.00 thousand.

What was BTAI's revenue growth in the past year?

As of Q2 2024, Bioxcel Therapeutics's revenue has grown 268% year over year. This is 119.6 percentage points higher than the US Biotechnology industry revenue growth rate of 148.4%. Bioxcel Therapeutics's revenue in the past year totalled $1.38 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.